Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

132 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
NK-104: a novel synthetic HMG-CoA reductase inhibitor.
Kajinami K, Mabuchi H, Saito Y. Kajinami K, et al. Expert Opin Investig Drugs. 2000 Nov;9(11):2653-61. doi: 10.1517/13543784.9.11.2653. Expert Opin Investig Drugs. 2000. PMID: 11060827 Review.
Effects of CS-514 (eptastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on serum lipid and apolipoprotein levels in heterozygous familial hypercholesterolemic patients treated by low density lipoprotein (LDL)-apheresis.
Mabuchi H, Fujita H, Michishita I, Takeda M, Kajinami K, Koizumi J, Takeda R, Takegoshi T, Wakasugi T, Ueda K, et al. Mabuchi H, et al. Among authors: kajinami k. Atherosclerosis. 1988 Aug;72(2-3):183-8. doi: 10.1016/0021-9150(88)90079-2. Atherosclerosis. 1988. PMID: 3145745
[Familial hypercholesterolemia].
Kajinami K, Mabuchi H. Kajinami K, et al. Ryoikibetsu Shokogun Shirizu. 1998;(19 Pt 2):67-72. Ryoikibetsu Shokogun Shirizu. 1998. PMID: 9645010 Review. Japanese. No abstract available.
132 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page